Avista Healthcare Public Acquisition Corp. Warrants
AHPAW
AHPAW was delisted on the 30th of October, 2018.
15 hedge funds and large institutions have $4.99M invested in Avista Healthcare Public Acquisition Corp. Warrants in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
Assured Investment Management
New York
|
+$1.23M |
| 2 |
FTCM
Fir Tree Capital Management
New York
|
+$882K |
| 3 |
HHC
Hutchin Hill Capital
New York
|
+$730K |
| 4 |
MCM
Moore Capital Management
New York
|
+$730K |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$584K |
Top Sellers
AHPAW Hedge Fund Activity: Q1 2017 in Review
15 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Avista Healthcare Public Acquisition Corp. Warrants (AHPAW) for Q1 2017, worth a combined $4.99M.
Buyers outnumbered sellers: 15 funds opened new AHPAW positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Assured Investment Management, opening a new position worth an estimated $1.23M.
- 15 institutional investors held Avista Healthcare Public Acquisition Corp. Warrants (AHPAW) as of Q1 2017, up from 0 in Q4 2016.
- Funds reported $4.99M of Avista Healthcare Public Acquisition Corp. Warrants stock for Q1 2017.
- 15 funds opened new Avista Healthcare Public Acquisition Corp. Warrants positions in Q1 2017 and 0 closed out, a net change of +15 holders.
- The largest Avista Healthcare Public Acquisition Corp. Warrants buyer in Q1 2017 was Assured Investment Management, an estimated $1.23M added.
Based on aggregated 13F filings for Q1 2017.